These conditions do not involve C-cells and do not increase susceptibility to potential GLP-1-mediated effects
Body aches , joint pain , insomnia , and anxiety are less common but reported by some users
It is not approved by any regulatory agency and cannot be obtained through prescription, pharmacy, or peptide suppliers
Similar alternative medications include Rybelsus and Jardiance, as well as other GLP-1 injectable drugs like Mounjaro, Trulicity, and Saxenda
These legal claims accuse Novo Nordisk and Eli Lilly of not sufficiently warning users about the risk of serious side effects, such as gastroparesis (a condition that slows stomach emptying), intestinal obstruction, and additional gastrointestinal harm linked to these drugs